Compare with Smith & Nephew SNATS, Inc.
1.48 USD
626.46 M USD
6.18 B USD
418.28 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Deepak S Nath
Website
Headquarters
Watford
Founded
1856
IPO date
Aug 13, 1951
ISIN
US83175M2052
CUSIP
83175M205
FIGI
BBG000C2W4K5
Identifiers
ISIN US83175M2052
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateSep 11, 2036
Coupon5.75% (Fixed)
Maturity dateMar 20, 2034
Coupon5.40% (Fixed)
Maturity dateOct 14, 2030
Coupon2.03% (Fixed)
Maturity dateJun 3, 2038
Coupon4.25% (Fixed)
Maturity dateOct 11, 2029
Coupon4.57% (Fixed)
See all SNN bonds








